· Monitoring of ADR’s must be more pro-active. This requires more funding, which should come from the main beneficiary of drug sales – the pharmaceutical industry – just as oversight of aviation safety is funded by the airlines.
· 必须更为高效地监控ADR’s。这要求更多的资金，而这些资金应当来源于药品销售的主要受益人——制药工业——正如航空安全的纰漏损失由航空公司来负担一样。